Unity Biotechnology (UBX) Competitors

Unity Biotechnology (NASDAQ:UBX) and Shattuck Labs (NASDAQ:STTK) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their community ranking, dividends, valuation, analyst recommendations, profitability, risk, media sentiment, earnings and institutional ownership.

Which has preferable earnings & valuation, UBX or STTK?

Unity Biotechnology has higher earnings, but lower revenue than Shattuck Labs. Unity Biotechnology is trading at a lower price-to-earnings ratio than Shattuck Labs, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Unity Biotechnology	$240K	68.17	-$39.86M	-$1.53	-0.63
Shattuck Labs	$5.72M	7.33	-$87.30M	-$1.49	-0.59

Does the media refer more to UBX or STTK?

In the previous week, Shattuck Labs had 1 more articles in the media than Unity Biotechnology. MarketBeat recorded 2 mentions for Shattuck Labs and 1 mentions for Unity Biotechnology. Unity Biotechnology's average media sentiment score of 1.89 beat Shattuck Labs' score of 0.93 indicating that Unity Biotechnology is being referred to more favorably in the media.

Company	Overall Sentiment
Unity Biotechnology	Very Positive
Shattuck Labs	Positive

Which has more risk and volatility, UBX or STTK?

Unity Biotechnology has a beta of 1.3, indicating that its stock price is 30% more volatile than the S&P 500. Comparatively, Shattuck Labs has a beta of 1.76, indicating that its stock price is 76% more volatile than the S&P 500.

Do analysts recommend UBX or STTK?

Unity Biotechnology currently has a consensus price target of $5.33, suggesting a potential upside of 449.83%. Shattuck Labs has a consensus price target of $7.50, suggesting a potential upside of 757.04%. Given Shattuck Labs' higher possible upside, analysts plainly believe Shattuck Labs is more favorable than Unity Biotechnology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Unity Biotechnology	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Shattuck Labs	0 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	2 Strong Buy rating(s)	2.71

Does the MarketBeat Community favor UBX or STTK?

Unity Biotechnology received 141 more outperform votes than Shattuck Labs when rated by MarketBeat users. However, 69.64% of users gave Shattuck Labs an outperform vote while only 67.16% of users gave Unity Biotechnology an outperform vote.

Company	Underperform	Outperform
Unity Biotechnology	Outperform Votes 180 67.16%	Underperform Votes 88 32.84%
Shattuck Labs	Outperform Votes 39 69.64%	Underperform Votes 17 30.36%

Do insiders & institutionals have more ownership in UBX or STTK?

29.5% of Unity Biotechnology shares are owned by institutional investors. Comparatively, 58.7% of Shattuck Labs shares are owned by institutional investors. 5.8% of Unity Biotechnology shares are owned by company insiders. Comparatively, 10.5% of Shattuck Labs shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Is UBX or STTK more profitable?

Unity Biotechnology has a net margin of 0.00% compared to Shattuck Labs' net margin of -1,156.46%. Shattuck Labs' return on equity of -61.92% beat Unity Biotechnology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Unity Biotechnology	N/A	-119.70%	-45.86%
Shattuck Labs	-1,156.46%	-61.92%	-54.49%

Summary

Shattuck Labs beats Unity Biotechnology on 11 of the 19 factors compared between the two stocks.